Latin America Insulin Market: By Source Type (Biologics and biosimilars); Indication (Type 1 and Type 2); Type (Rapid-Acting Short-Acting, Intermediate-Acting, Long-Acting, Premixed); Region—Market Analysis and Forecast for 2023–2031
Latin America insulin market was valued at US$ 2,855.1 million in 2022 and is projected to attain a valuation of US$ 3,857.50 million by 2031 at a CAGR of 3.4% during the forecast period 2023–2031. Read More
We Are Trusted By These Great Companies!
Published On: 08-Jul-2023 | Format: | Report ID: AA0723506